These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 7593814)
1. CD31 immunoreactivity in mesenchymal neoplasms of the skin and subcutis: report of 145 cases and review of putative immunohistologic markers of endothelial differentiation. DeYoung BR; Swanson PE; Argenyi ZB; Ritter JH; Fitzgibbon JF; Stahl DJ; Hoover W; Wick MR J Cutan Pathol; 1995 Jun; 22(3):215-22. PubMed ID: 7593814 [TBL] [Abstract][Full Text] [Related]
2. Immunostaining for CD31 and CD34 in Kaposi sarcoma. Russell Jones R; Orchard G; Zelger B; Wilson Jones E J Clin Pathol; 1995 Nov; 48(11):1011-6. PubMed ID: 8543622 [TBL] [Abstract][Full Text] [Related]
3. On the discriminatory value of anti-HPCA-1 (CD-34) in the differential diagnosis of benign and malignant cutaneous vascular proliferations. Suster S; Wong TY Am J Dermatopathol; 1994 Aug; 16(4):355-63. PubMed ID: 7526723 [TBL] [Abstract][Full Text] [Related]
4. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Miettinen M; Lindenmayer AE; Chaubal A Mod Pathol; 1994 Jan; 7(1):82-90. PubMed ID: 7512718 [TBL] [Abstract][Full Text] [Related]
5. Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas. Poblet E; Gonzalez-Palacios F; Jimenez FJ Virchows Arch; 1996 Jul; 428(4-5):217-21. PubMed ID: 8764929 [TBL] [Abstract][Full Text] [Related]
6. CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma. Pammer J; Plettenberg A; Weninger W; Diller B; Mildner M; Uthman A; Issing W; Stürzl M; Tschachler E Am J Pathol; 1996 May; 148(5):1387-96. PubMed ID: 8623911 [TBL] [Abstract][Full Text] [Related]
7. Immunoreactivity of sinusoids in hepatoblastoma: an immunohistochemical study using lectin UEA-1 and antibodies against endothelium-associated antigens, including CD34. Ruck P; Xiao JC; Kaiserling E Histopathology; 1995 May; 26(5):451-5. PubMed ID: 7544763 [TBL] [Abstract][Full Text] [Related]
8. Use of immunohistochemical procedures in diagnosing angiosarcoma. Evaluation of 98 cases. Ohsawa M; Naka N; Tomita Y; Kawamori D; Kanno H; Aozasa K Cancer; 1995 Jun; 75(12):2867-74. PubMed ID: 7773935 [TBL] [Abstract][Full Text] [Related]
9. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Breiteneder-Geleff S; Soleiman A; Kowalski H; Horvat R; Amann G; Kriehuber E; Diem K; Weninger W; Tschachler E; Alitalo K; Kerjaschki D Am J Pathol; 1999 Feb; 154(2):385-94. PubMed ID: 10027397 [TBL] [Abstract][Full Text] [Related]
10. Immunoreactivity of sinusoids in hepatocellular carcinoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34. Ruck P; Xiao JC; Kaiserling E Arch Pathol Lab Med; 1995 Feb; 119(2):173-8. PubMed ID: 7531428 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Vascular Markers (Immunohistochemical Stains) in Soft Tissue Sarcomas. Naeem N; Mushtaq S; Akhter N; Hussain M; Hassan U J Coll Physicians Surg Pak; 2018 May; 28(5):352-356. PubMed ID: 29690962 [TBL] [Abstract][Full Text] [Related]
12. Cultured Kaposi's sarcoma cell lines express factor XIIIa, CD14, and VCAM-1, but not factor VIII or ELAM-1. Huang YQ; Friedman-Kien AE; Li JJ; Nickoloff BJ Arch Dermatol; 1993 Oct; 129(10):1291-6. PubMed ID: 7692824 [TBL] [Abstract][Full Text] [Related]
13. [Tufted hemangioma. Clinicopathologic and immunohistologic analysis of 5 cases of a distinct entity within the spectrum of capillary hemangioma]. Mentzel T; Wollina U; Castelli E; Kutzner H Hautarzt; 1996 May; 47(5):369-75. PubMed ID: 8707583 [TBL] [Abstract][Full Text] [Related]
14. The use of CD31 and collagen IV as vascular markers. A study of 56 vascular lesions. Schmidt D; von Hochstetter AR Pathol Res Pract; 1995 Jun; 191(5):410-4. PubMed ID: 7479359 [TBL] [Abstract][Full Text] [Related]
16. Expression of CD105 (endoglin) in arteriolar endothelial cells of human endometrium throughout the menstrual cycle. Zhang EG; Smith SK; Charnock-Jones DS Reproduction; 2002 Nov; 124(5):703-11. PubMed ID: 12417009 [TBL] [Abstract][Full Text] [Related]
17. PECAM-1 (CD31) is expressed on proliferating endothelial cells, stromal spindle-shaped cells, and dermal dendrocytes in Kaposi's sarcoma. Nickoloff BJ Arch Dermatol; 1993 Feb; 129(2):250-1. PubMed ID: 8434991 [No Abstract] [Full Text] [Related]
18. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Folpe AL; Veikkola T; Valtola R; Weiss SW Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276 [TBL] [Abstract][Full Text] [Related]
19. [Characteristics of ERG, Fli-1, CD34, CD31 and FⅧRAg expression in hepatic malignant vascular tumors]. Wang ZB; An XJ; Deng JF; Liu JH; Shi HY Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):760-763. PubMed ID: 29136688 [No Abstract] [Full Text] [Related]
20. Cutaneous vascular proliferation. Part II. Hyperplasias and benign neoplasms. Requena L; Sangueza OP J Am Acad Dermatol; 1997 Dec; 37(6):887-919; quiz 920-2. PubMed ID: 9418757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]